Healthcare provider profile · identity verified

Harry T Williams, MD

Family Practice · VIRGINIA BEACH, VA · NPI 1366417321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	641	193
Lisinopril	Lisinopril	332	101
Simvastatin	Simvastatin	320	97
Amlodipine Besylate	Amlodipine Besylate	309	100
Levothyroxine Sodium	Levothyroxine Sodium	294	93
Hydrochlorothiazide	Hydrochlorothiazide	208	65
Losartan Potassium	Losartan Potassium	206	66
Omeprazole	Omeprazole	199	60
Tamsulosin Hcl	Tamsulosin Hcl	156	52
Gabapentin	Gabapentin	149	46
Alprazolam	Alprazolam	147	31
Pravastatin Sodium	Pravastatin Sodium	143	49
Rosuvastatin Calcium	Rosuvastatin Calcium	141	54
Metformin Hcl Er	Metformin Hcl	137	48
Pantoprazole Sodium	Pantoprazole Sodium	125	41
Citalopram Hbr	Citalopram Hydrobromide	124	38
Zolpidem Tartrate	Zolpidem Tartrate	118	23
Eliquis	Apixaban	107	33
Carvedilol	Carvedilol	106	33
Tramadol Hcl	Tramadol Hcl	102	28
Metoprolol Succinate	Metoprolol Succinate	100	31
Metformin Hcl	Metformin Hcl	96	28
Fluticasone Propionate	Fluticasone Propionate	91	55
Atenolol	Atenolol	87	23
Furosemide	Furosemide	86	29
Alendronate Sodium	Alendronate Sodium	81	24
Potassium Chloride	Potassium Chloride	79	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	suppressed
Trazodone Hcl	Trazodone Hcl	74	29
Metoprolol Tartrate	Metoprolol Tartrate	73	24
Ozempic	Semaglutide	72	13
Sertraline Hcl	Sertraline Hcl	68	25
Montelukast Sodium	Montelukast Sodium	64	19
Albuterol Sulfate Hfa	Albuterol Sulfate	63	27
Duloxetine Hcl	Duloxetine Hcl	63	21
Ezetimibe	Ezetimibe	62	21
Jardiance	Empagliflozin	62	17
Fluoxetine Hcl	Fluoxetine Hcl	61	19
Allopurinol	Allopurinol	59	19
Synthroid	Levothyroxine Sodium	58	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	12
Glimepiride	Glimepiride	55	21
Vitamin D2	Ergocalciferol (Vitamin D2)	53	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	16
Ibuprofen	Ibuprofen	51	16
Celecoxib	Celecoxib	50	15
Clopidogrel	Clopidogrel Bisulfate	47	17
Ropinirole Hcl	Ropinirole Hcl	46	11
Escitalopram Oxalate	Escitalopram Oxalate	43	12
Famotidine	Famotidine	43	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Pregabalin	Pregabalin	43	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	41	11
Warfarin Sodium	Warfarin Sodium	41	12
Prednisone	Prednisone	40	20
Bupropion Xl	Bupropion Hcl	39	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	13
Diclofenac Sodium	Diclofenac Sodium	37	16
Xarelto	Rivaroxaban	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Temazepam	Temazepam	33	11
Lorazepam	Lorazepam	31	11
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	23
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	13
Spironolactone	Spironolactone	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Meloxicam	Meloxicam	28	12
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Naproxen	Naproxen	21	11
Ondansetron Odt	Ondansetron	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Bumetanide	Bumetanide	20	suppressed
Diazepam	Diazepam	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	11
Finasteride	Finasteride	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	14
Fenofibrate	Fenofibrate	16	suppressed
Fluocinonide	Fluocinonide	16	12
Klor-Con M20	Potassium Chloride	16	suppressed
Multaq	Dronedarone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Glipizide	Glipizide	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Nystatin	Nystatin	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fluorouracil	Fluorouracil	14	13
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Emgality Syringe	Galcanezumab-Gnlm	13	suppressed
Naloxone Hcl	Naloxone Hcl	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Ramipril	Ramipril	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error